Search

Search results

91 results found

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.

Wysocki, Oskar, Cong Zhou, Jacobo Rogado, Prerana Huddar, Rohan Shotton, Ann Tivey, Laurence Albiges, et al. 2022. “An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients With Cancer Presenting With COVID-19 across Different Pandemic Waves.”. Cancers 14 (16).

Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4).

The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt.

Chiang, George J, Brian R Billmeyer, David Canes, John Stoffel, Alireza Moinzadeh, Christina A Austin, Monika Kosakowski, Kimberly M Rieger-Christ, John A Libertino, and Ian C Summerhayes. 2005. “The Src-Family Kinase Inhibitor PP2 Suppresses the in Vitro Invasive Phenotype of Bladder Carcinoma Cells via Modulation of Akt.”. BJU International 96 (3): 416-22.

Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo.

Canes, David, George J Chiang, Brian R Billmeyer, Christina A Austin, Monika Kosakowski, Kimberly M Rieger-Christ, John A Libertino, and Ian C Summerhayes. 2005. “Histone Deacetylase Inhibitors Upregulate Plakoglobin Expression in Bladder Carcinoma Cells and Display Antineoplastic Activity in Vitro and in Vivo.”. International Journal of Cancer 113 (5): 841-8.